Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 68

1.
2.

Hypermethylation of the gene promoter and enhancer region can regulate Fas expression and sensitivity in colon carcinoma.

Petak I, Danam RP, Tillman DM, Vernes R, Howell SR, Berczi L, Kopper L, Brent TP, Houghton JA.

Cell Death Differ. 2003 Feb;10(2):211-7.

3.

CDX1 expression is reduced in colorectal carcinoma and is associated with promoter hypermethylation.

Pilozzi E, Onelli MR, Ziparo V, Mercantini P, Ruco L.

J Pathol. 2004 Nov;204(3):289-95.

PMID:
15378566
4.

Methylation of CpG sites in exon 2 of the bcl-2 gene occurs in colorectal carcinoma.

Babidge WJ, Butler LM, Burton MA, Cowled PA.

Anticancer Res. 2001 Jul-Aug;21(4A):2809-14.

PMID:
11724359
5.
6.

Aberrant methylation of the specific CpG island portion regulates cyclooxygenase-2 gene expression in human gastric carcinomas.

Hur K, Song SH, Lee HS, Ho Kim W, Bang YJ, Yang HK.

Biochem Biophys Res Commun. 2003 Oct 24;310(3):844-51.

PMID:
14550281
7.

Downregulation of CD44v6 in colorectal carcinomas is associated with hypermethylation of the CD44 promoter region.

Stallmach A, Wittig BM, Kremp K, Goebel R, Santourlidis S, Zeitz M, Menges M, Raedle J, Zeuzem S, Schulz WA.

Exp Mol Pathol. 2003 Jun;74(3):262-6.

PMID:
12782013
8.

The breakdown of apoptotic mechanism in the development and progression of colorectal carcinoma.

Ogawa S, Nagao M, Kanehiro H, Hisanaga M, Ko S, Ikeda N, Nakajima Y.

Anticancer Res. 2004 May-Jun;24(3a):1569-79.

10.

Close localization of DAP-kinase positive tumour-associated macrophages and apoptotic colorectal cancer cells.

Schneider-Stock R, Kuester D, Ullrich O, Mittag F, Habold C, Boltze C, Peters B, Krueger S, Hintze C, Meyer F, Hartig R, Roessner A.

J Pathol. 2006 May;209(1):95-105.

PMID:
16575786
11.

Frequent hypermethylation of CpG islands and loss of expression of the 14-3-3 sigma gene in human hepatocellular carcinoma.

Iwata N, Yamamoto H, Sasaki S, Itoh F, Suzuki H, Kikuchi T, Kaneto H, Iku S, Ozeki I, Karino Y, Satoh T, Toyota J, Satoh M, Endo T, Imai K.

Oncogene. 2000 Nov 2;19(46):5298-302.

12.
13.

Frequent epigenetic silencing of the CpG island promoter of RASSF1A in thyroid carcinoma.

Schagdarsurengin U, Gimm O, Hoang-Vu C, Dralle H, Pfeifer GP, Dammann R.

Cancer Res. 2002 Jul 1;62(13):3698-701.

14.

Loss of pRb expression in pituitary adenomas is associated with methylation of the RB1 CpG island.

Simpson DJ, Hibberts NA, McNicol AM, Clayton RN, Farrell WE.

Cancer Res. 2000 Mar 1;60(5):1211-6.

15.

Fas ligand upregulation is an early event in colonic carcinogenesis.

Bennett MW, O'Connell J, Houston A, Kelly J, O'Sullivan GC, Collins JK, Shanahan F.

J Clin Pathol. 2001 Aug;54(8):598-604.

16.
17.

Frequent loss of Fas expression and function in human lung tumours with overexpression of FasL in small cell lung carcinoma.

Viard-Leveugle I, Veyrenc S, French LE, Brambilla C, Brambilla E.

J Pathol. 2003 Oct;201(2):268-77.

PMID:
14517844
18.

[CpG island methylation of E-cadherin gene promoter in gastric carcinoma].

Zhou YN, Xu CP, Han B, Ji R.

Ai Zheng. 2005 Oct;24(10):1220-4. Chinese.

PMID:
16219136
19.
20.

Tumour-specific distribution of BRCA1 promoter region methylation supports a pathogenetic role in breast and ovarian cancer.

Bianco T, Chenevix-Trench G, Walsh DC, Cooper JE, Dobrovic A.

Carcinogenesis. 2000 Feb;21(2):147-51.

PMID:
10657950

Supplemental Content

Support Center